Antibodies that bind specifically to receptor for advanced glycation end products (RAGE) and RAGE-binding fragments thereof are disclosed.
本发明揭示与晚期糖化终产物受体(RAGE)特异性结合的抗体及其RAGE结合片段。
In particular, the cell binding agent is a monoclonal antibody, and epitope-binding fragments thereof, that recognizes and binds the CD38 protein.
特别的，细胞结合剂是识别并结合CD38蛋白的单 克隆抗体、其表位结合片段。
The purpose of the paper is to build a module of small molecular receptor fragments charactering normal VLDL-R binding function and study the mechanism of VLDL-R binding to ligand.
建立具有正常极低密度脂蛋白（VLDL）受体结合功能的小分子受体片段模型并借助此模型研究VLDL受体与配体结合的作用机制。
The primer was designed based on consensus sequence from RRM RNA binding protein gene family. The results showed that there were stable expressed fragments among the different mRNA samples.
不同材料间具有稳定表达的组成型RRMRNA结合蛋白基因，同时具有丰富的差异表达的具调控功能的RRM RNA结合蛋白基因。
Also disclosed are pharmaceutical compositions comprising such anti-RAGE antibodies and RAGE-binding antibody fragments thereof, and their use for treatment of RAGE related diseases.
本发明也揭示包含所述抗rage抗体及其RAGE结合抗体片段的医药组合物及其用于治疗RAGE相关疾病的用途。
Nucleopeptides can be synthesized as the fragments of nucleoprotein at binding position and used as a tool for the investigation of the mechanism of biological e...
核肽也指合成的核蛋白结合位点的片断，作为一种新的工具既可用于研究核蛋白产生生物效应的机理，又为开发新一类抗病毒、抗肿瘤药物开辟了道路。
Nucleopeptides can be synthesized as the fragments of nucleoprotein at binding position and used as a tool for the investigation of the mechanism of biological e...
核肽也指合成的核蛋白结合位点的片断，作为一种新的工具既可用于研究核蛋白产生生物效应的机理，又为开发新一类抗病毒、抗肿瘤药物开辟了道路。
应用推荐